Vaxart, Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+586.5% +$89M
$104M
Cost of Revenue
—
R&D↑+99.3% +$22M
$45M
SG&A
—
D&A↓-8.1% -$181K
$2M
Operating Income
$26M
EBITDA↑+1149.6% +$26M
$28M
Interest Expense↓-9.1% -$55K
$547K
Interest Income
—
Other Income/Expense
$-411K
Pretax Income
$25M
Tax Provision↑+95.5% +$168K
$344K
Net Income
$24M
Operating Margin
24.8%
Net Margin
23.5%
Effective Tax Rate
1.4%
Tax Credit Carryforwards
—
ETR (Continuing Operations)↑+3.2pts
2.8%
ETR Federal Statutory
21.0%
ETR State + Local (pp)↓-0.1pts
0.0%
ETR Foreign Differential (pp)↑+0.7pts
0.0%
Operating Lease Cost↓-25.1% -$390K
$1M
Revenue YoY Variation↑+218.5pts
586.5%
Income YoY Variation↑+27.3pts
46.0%
Revenue QoQ Variation↓-163.9pts
44.0%
Income QoQ Variation
431.4%